Endocrinology

The Dermapace System is intended for adults at least 22 years old, with diabetic foot ulcers lasting more than 30 days.

The risk of major birth defects was 6% higher due to a diagnosis of pre-gestational diabetes than without the presence of the condition.

Findings indicated that Macrilen stimulated the pituitary gland to produce the growth hormone more effectively than the ITT.

Ertugliflozin, an SGLT2 inhibitor from Merck & Co. and Pfizer, was approved as both a monotherapy and fixed-dose combination therapy.

Women who had experienced gestational diabetes were at a 43% higher risk for CVD events, such as myocardial infarction or stroke.

Research showed that 30% of metformin doses were not taken by patients with type 2 diabetes.

The real-world data revealed a U-shaped relationship between glycemic control and CV disease risk, according to the authors.

Medtronic's MiniMed 670G Insulin Pump System alleviates a huge patient burden for T1D patients and gives hope for a similar device for T2D.

The study found that 5.6% of all incident cancers from 5 years ago were attributable to the combined effects of diabetes and high BMI.

Continuous glucose monitoring was shown to lower the risk of hyperglycemia compared to capillary glucose monitoring alone.

OZEMPIC, a GLP-1 receptor agonist, was tested in 2-year cardiovascular outcome trials.

Reddit's Ask Me Anything forums have proven to give physicians a chance to connect with and educate thousands of people at once.

With a dozen-plus agent classes for diabetes, what do physicians address first in patients?

Average daily blood glucose during the study was 152 mg/dL, down from 71 mg/dL - or 32% - from the average admission blood glucose, and below the goal range.

Lifestyle modification was associated with a relative risk reduction of 39% compared to 36% for medications.

To image or not to image: A new study validates professional society recommendations on follow-up strategies for adrenal masses. 

Carlos Grilo, PhD, explains what sort of biases obese and binge-eating disorder patients suffer in pubic and health care settings, and how doctors can re-adjust their approach.

Eliot Brinton, MD, President of the Utah Lipid Center, explains the potential of liraglutide, semaglutide, and it's related therapies for type 2 diabetes.

The AACE/ACE 2017 recommendations on lipid management renew focus on LDL-C targets, and go far lower than any group has ventured to date.

Janssen's T2D drug for CV risks is undergoing a kidney disease-based phase 3 trial now.

FDA sends response letter for deficiencies found in Antares Pharma’s QuickShot Testosterone auto injector.

James Underberg, MD, President-Elect of the National Lipid Association, Clinical Assistant Professor of Medicine, NYU School of Medicine, NYU Center for the Prevention of Cardiovascular Disease, discusses statin intolerance and the future of cholesterol treatments.

The Certified Nurse Practicioner from the Henry Ford Medical Center also weighs in the best advice to avoid cardiovascular disease.

The FreeStyle Libre Flash Glucose Monitoring System reduces the requirement of “fingerstick” testing, with small sensor wire that continuously monitors and measures levels.

The New York University clinical professor of medicine also shared his thoughts on the future of cardiovascular disease medicine.

The Glucommander software showed patients were able to rapidly control their glucose levels and maintain their control long-term.

While previous research has shown a link between eating meat and the risk of developing type 2 diabetes, a new study is the first to evaluate the risk in people eating an eastern diet.

Patient-driven doses led to 67.5% of subjects reaching target HbA1C compared to 58.4% in the physician-driven arm.